World Journal of Surgery

, Volume 34, Issue 6, pp 1312–1317 | Cite as

Removal of Autografted Parathyroid Tissue for Recurrent Renal Hyperparathyroidism in Hemodialysis Patients

  • Yoshihiro Tominaga
  • Susumu Matsuoka
  • Nobuaki Uno
  • Toyonori Tsuzuki
  • Takahisa Hiramitsu
  • Norihiko Goto
  • Takaharu Nagasaka
  • Yoshihiko Watarai
  • Kazuharu Uchida



Recurrent renal hyperparathyroidism (HPT) is a serious problem after parathyroidectomy (PTx). We evaluated the frequency of graft-dependent recurrent HPT and the clinical outcomes after removal of the autograft.


Between March 1980 and January 2009, 2660 patients underwent total PTx with forearm autograft. After resection of all parathyroid glands, 30 pieces of 1 × 1 × 3 mm parathyroid tissue from diffuse hyperplasia, if possible, were autografted into brachioradial muscle. Graft-dependent recurrence of HPT was diagnosed by a high PTH gradient and detection of swollen autografts by palpation and/or MRI or US.


In 248/2660 (9.3%) patients, removal of the graft was required a total of 327 times (53 patients required removal of the autograft several times). The cumulative frequency of graft-dependent recurrent HPT was 17.4% ten years after the initial PTx. Thirty-two patients underwent both resection of missed glands located in the neck or mediastinum and removal of the graft. En-bloc resection of autograft with surrounding muscle was required to avoid reoperation. When the intact PTH level dropped under 300 pg/ml, in the majority of patients renal HPT could be medically managed after the operation. The mean weight of the resected parathyroid tissue was 1583.7 mg. No specimen had histopathologically malignant features. Three patients suffered from hematoma in the wound.


Graft-dependent recurrent renal HPT is not negligible. However, in the majority of patients, renal HPT can be controlled by removal of the autograft noninvasively. Total PTx with forearm autograft is preferable for hemodialysis patients, especially when long-term survival is expected.


Parathyroid Gland Parathyroid Carcinoma Parathyroid Tissue Hyperplastic Parathyroid Tissue Forearm Autograft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Professor Henry Johansson, Department of Surgery, Uppsala University Hospital, Sweden, for his kind advice on the manuscript.


  1. 1.
    Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis patients. J Am Soc Nephrol 15:2208–2218CrossRefPubMedGoogle Scholar
  2. 2.
    Tominaga Y, Matsuoka S, Uno N (2009) Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg 33(11):2335–2342CrossRefPubMedGoogle Scholar
  3. 3.
    National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S140Google Scholar
  4. 4.
    Andia JBC, Drueke TB, Cunningham J et al (2000) Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 15(Suppl 5):2–57Google Scholar
  5. 5.
    Japanese Society for Dialysis Therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 12:514–525CrossRefGoogle Scholar
  6. 6.
    Tominaga Y (2006) Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 111:277–292CrossRefPubMedGoogle Scholar
  7. 7.
    Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9:44–47CrossRefPubMedGoogle Scholar
  8. 8.
    Tominaga Y (2008) Current status of parathyroidectomy for secondary hyperparathyroidism in Japan. NDT Plus 1(Suppl 3):iii35–iii38CrossRefGoogle Scholar
  9. 9.
    Hibi Y, Tominaga Y, Sato T et al (2002) Reoperation for renal hyperparathyroidism. World J Surg 26:1301–1307CrossRefPubMedGoogle Scholar
  10. 10.
    De-Francisco AL, Amado JA, Casanova D et al (1991) Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: a new technique to localize source of hormone excess. Nephron 58:306–309CrossRefPubMedGoogle Scholar
  11. 11.
    Malberti F, Marcelli D, Conte F et al (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12:1242–1248PubMedGoogle Scholar
  12. 12.
    Basile C, Lomonte C, Vernaglione L et al (2006) A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant 21:968–974CrossRefPubMedGoogle Scholar
  13. 13.
    Jorna FH, Tobe TJM, Huisman RM et al (2004) Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 19:1168–1173CrossRefPubMedGoogle Scholar
  14. 14.
    Stratton J, Simcock M, Thompson H (2003) Predictors of recurrent hyperparathyroidism after total parathyroidectomy in chronic renal failure. Nepron Clin Pract 95:c15–c22CrossRefGoogle Scholar
  15. 15.
    Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15:745–750CrossRefPubMedGoogle Scholar
  16. 16.
    Hargrove GM, Pasieka JL, Hanley DA et al (1999) Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol 19:559–564CrossRefPubMedGoogle Scholar
  17. 17.
    Zaraca F, Mazzaferro S, Catarci M et al (1999) Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism. Arch Surg 134:68–72CrossRefPubMedGoogle Scholar
  18. 18.
    Feldman AL, Sharaf RN, Skarulis MC et al (1999) Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 126:1042–1048CrossRefPubMedGoogle Scholar
  19. 19.
    Skinner KA, Zuckerbraun L (1996) Recurrent secondary hyperparathyroidism. Arch Surg 131:724–727PubMedGoogle Scholar
  20. 20.
    Zhong A, Billa V, Rotstein LE et al (2000) Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patients. Perit Dial Int 20:200–208PubMedGoogle Scholar
  21. 21.
    Niederle B, Roka R, Brennan MF (1982) The transplantation of parathyroid tissue in man: development, indication, technique and results. Endocr Rev 3:245CrossRefPubMedGoogle Scholar
  22. 22.
    Tominaga Y, Tanaka Y, Sato K et al (1992) Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595–603CrossRefPubMedGoogle Scholar
  23. 23.
    Tominaga Y, Tanaka Y, Sato K et al (1996) DNA studies in graft dependent hyperparathyroidism. Acta Chir Austriaca 28(Suppl 124):65–68Google Scholar
  24. 24.
    Neyer U, Hoerandner H, Haid A et al (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17:625–629CrossRefPubMedGoogle Scholar
  25. 25.
    Hampl H, Steinmuller T, Frohling P et al (1999) Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner Electrolyte Metab 25:161–170CrossRefPubMedGoogle Scholar
  26. 26.
    Lorenz K, Ukkat J, Sekulla C et al (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30:743–751CrossRefPubMedGoogle Scholar
  27. 27.
    Ljutic D, Cameron JS, Ogg CS et al (1994) Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. QJM 87:685–692PubMedGoogle Scholar
  28. 28.
    Stracke S, Jehle PM, Sturm D et al (1999) Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 33:304–311CrossRefPubMedGoogle Scholar
  29. 29.
    Shih ML, Duh QY, Hsieh CB et al (2009) Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 33:248–254CrossRefPubMedGoogle Scholar
  30. 30.
    Aly A, Douglas M (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 73:284–288CrossRefPubMedGoogle Scholar
  31. 31.
    Uno N, Tominaga Y, Matsuoka S et al (2008) Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 32:2516–2519CrossRefPubMedGoogle Scholar
  32. 32.
    Richards ML, Wormuth J, Bingener J et al (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139:174–180CrossRefPubMedGoogle Scholar
  33. 33.
    Klempa I, Frei U, Rottger P et al (1984) Parathyroid autograft morphology and function: six years’ experience with parathyroid autotransplantation in uremic patients. World J Surg 8:540–544CrossRefPubMedGoogle Scholar
  34. 34.
    Wells SA, Gunnells JC, Shelbourne JD et al (1975) Transplantation of parathyroid glands in men: clinical indications and results. Surgery 78:34–44PubMedGoogle Scholar
  35. 35.
    Tominaga Y, Tsuzuki T, Matsuoka S et al (2008) Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32:815–821CrossRefPubMedGoogle Scholar
  36. 36.
    Matsuoka S, Tominaga Y, Sato T et al (2006) Recurrent renal hyperparathyroidism caused by parathyromatois. Word J Surg 31:299–305CrossRefGoogle Scholar
  37. 37.
    Lomonte C, Antonelli M, Losurdo N et al (2007) Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy. Nephrol Dial Transplant 22:2056–2062CrossRefPubMedGoogle Scholar
  38. 38.
    Silverberg SJ, Rubin MR, Faiman C et al (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808CrossRefPubMedGoogle Scholar
  39. 39.
    Eriguchi R, Umakoshi J, Tominaga Y et al (2008) Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl. NDT Plus 4:218–220CrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • Yoshihiro Tominaga
    • 1
  • Susumu Matsuoka
    • 1
  • Nobuaki Uno
    • 1
  • Toyonori Tsuzuki
    • 2
  • Takahisa Hiramitsu
    • 1
  • Norihiko Goto
    • 1
  • Takaharu Nagasaka
    • 1
  • Yoshihiko Watarai
    • 1
  • Kazuharu Uchida
    • 1
  1. 1.Department of Transplant and Endocrine SurgeryNagoya Second Red Cross HospitalNagoyaJapan
  2. 2.Department of PathologyNagoya Second Red Cross HospitalNagoyaJapan

Personalised recommendations